These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36322146)

  • 21. Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
    Cleanthous S; Mork AC; Regnault A; Cano S; Kaminski HJ; Morel T
    Orphanet J Rare Dis; 2021 Oct; 16(1):457. PubMed ID: 34717694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different characteristics of nonthymomatous generalized myasthenia gravis with and without oropharyngeal involvement.
    Yu L; Li J; Ma S; Jiang J; Wang T; Gamliel Z; Jing Y; Zhang X; Krasna MJ
    Ann Thorac Surg; 2007 Nov; 84(5):1694-8. PubMed ID: 17954087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative interview study of patient-reported symptoms, impacts and treatment goals of patients with obstructive hypertrophic cardiomyopathy.
    Shore S; Ervin C; Kosa K; Fehnel S; Salberg L; Butzner M; Heitner SB; Jacoby D; Saberi S
    BMJ Open; 2024 Sep; 14(9):e081323. PubMed ID: 39289016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diaphragmatic ultrasonography as a predictor of respiratory muscle fatigue in myasthenia gravis.
    Ma J; Zhang H; Pang X; Zhang J; Zhao R; Wang J; Chang X; Guo J; Zhang W
    Muscle Nerve; 2024 Feb; 69(2):199-205. PubMed ID: 38124677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
    Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
    Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective.
    Mengel E; Patterson MC; Chladek M; Guldberg C; Í Dali C; Symonds T; Lloyd-Price L; Mathieson T; Crowe J; Burbridge C
    Orphanet J Rare Dis; 2021 Nov; 16(1):493. PubMed ID: 34819124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies.
    Aguirre F; Andrade R
    J Comp Eff Res; 2024 Nov; 13(11):e240109. PubMed ID: 39387235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing the Patient Journey in Multiple Myeloma: Qualitative Review.
    Lyall M; Crawford R; Bell T; Mamolo C; Neuhof A; Levy C; Heyes A
    JMIR Cancer; 2022 Sep; 8(3):e39068. PubMed ID: 36136395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of symptom severity and fatigue on sleep quality in patients with myasthenia gravis.
    Yeşil Demirci P; Eskimez Z; Bozdoğan Yeşilot S
    Neurol Res; 2024 Jan; 46(1):42-48. PubMed ID: 37700391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment.
    Drahos J; Boateng-Kuffour A; Calvert M; Levine L; Dongha N; Li N; Pakbaz Z; Shah F; Martin AP
    Patient; 2024 Jul; 17(4):421-439. PubMed ID: 38530509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Ethnographic Study of Patient Life Experience in Early-Stage Parkinson's Disease in the United States and Germany.
    Carmody T; Park R; Bennett E; Kuret E; Klein B; Costa À; Messner S; Hursey A
    Neurol Ther; 2024 Aug; 13(4):1219-1235. PubMed ID: 38865073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bothersome symptoms during the late reproductive stage and menopausal transition: observations from the Women Living Better Survey.
    Woods NF; Coslov N; Richardson MK
    Menopause; 2023 Jan; 30(1):45-55. PubMed ID: 36576442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS).
    Hitchcock I; Skrobanski H; Matter E; Munro E; Whalen J; Nolthenius JT; Crocker-Buque A; Harrington A; Vandenberghe D; Acaster S; Williams K
    Orphanet J Rare Dis; 2024 May; 19(1):203. PubMed ID: 38760658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Experience With Fatigue and Qualitative Interview-Based Evidence of Content Validation of The FACIT-Fatigue in Systemic Lupus Erythematosus.
    Raymond K; Park J; Joshi AV; White MK
    Rheumatol Ther; 2021 Mar; 8(1):541-554. PubMed ID: 33687688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring treatment impacts on symptoms in adults with hypoparathyroidism: findings from the PaTHway trial.
    Brod M; Pfeiffer KM; Beck JF; Smith A
    J Patient Rep Outcomes; 2024 Aug; 8(1):94. PubMed ID: 39136801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
    Vissing J; Jacob S; Fujita KP; O'Brien F; Howard JF;
    J Neurol; 2020 Jul; 267(7):1991-2001. PubMed ID: 32189108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.